Abstract:The clinical data of a case of retroperitoneal schwannoma in the Dongfang Hospital Attached to Beijing University of Traditional Chinese Medicine in 2018 were analyzed retrospectively in order to investigate the diagnosis and treatment of POEMS syndrome. Multiple peripheral neuropathy is not only the main clinical manifestation of POEMS syndrome patients, but also the first symptom. Almost all patients with this disease have the protein cell separation phenomenonin in the cerebrospinal fluid, which is easy to be misdiagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP). Early treatment is beneficial to reduce the degree of disease damage and increase the survival rate, so early diagnosis is very important. This patient was misdiagnosed as CIDP for two and a half years. During this period, the patient developed multiple system symptoms, and went to many departments of many hospitals for treatment. While, the patient was not diagnosed correctly all the time. The patient was suffering physically and mentally, which cost a lot of human, material and financial resources. In this study, the case report combined with literature review can help guide clinicians to correctly diagnose patients with POEMS syndrome as soon as possible, so that patients can benefit the most.
张娜 陈志刚 李楠楠. 误诊为慢性格林巴利的POEMS综合征1例[J]. 中国医药导报, 2019, 16(36): 153-156.
ZHANG Na CHEN Zhigang LI Nannan. A case of POEMS syndrome misdiagnosed as chronic inflammatory demyelinating polyneuropathy. 中国医药导报, 2019, 16(36): 153-156.
[1] Schwarz R,Horger M. POEMS syndrome [J]. Rofo,2018, 190(2):106-110.
[2] Katipoglu B,Katipoglu Z,Ates I,et al. A rare cause of pericardial effusion and ascites:POEMS syndrome [J]. Hemato,2017,9(4):7384.
[3] Dispenzieri A,Kourelis T,Buadi F. POEMS syndrome diagnosis and investigative work-up [J]. Hematol Oncol Clin North Am,2018,32(1):19-139.
[4] 马丽娜,于生元,刘若卓,等.血清血管内皮生长因子对POEMS综合征的早期诊断[J].武警医学,2015,26(12):1210-1212.
[5] 曹欣欣,王琛,蔡昊,等.血清血管内皮生长因子水平对POEMS综合征的诊断意义及其临床相关性研究[J].中华血液学杂志,2014,35(12):1065-1068.
[6] Nozza A. POEMS syndrome:an update [J]. Mediterr J Hematol Infect Dis,2017,9(1):e2 017 051.
[7] 季丽莉,王钦,张雪皎,等.血清血管内皮生长因子在诊断POEMS综合征中的作用(附2例报告)[J].中国临床神经科学,2016,24(3):288-293.
[8] 杨磊,徐依成,于玲,等.POEMS 综合征五例诊治剖析[J].临床误诊误治,2016,29(3):21-24.
[9] 吴婷婷,章必成,冉启杰,等.POEMS 综合征长期误诊并文献复习[J].临床误诊误治,2015,28(9):13-16.
[10] Dispenzieri A. POEMS syndrome:2017 Update on diagnosis,risk stratification,and management [J]. American journal of hematology. 2017,92(8):814-829.
[11] 崔丽英.神经内科疾病临床诊疗思维[M].北京:人民卫生出版社,2011.
[12] Mauermann ML. The Peripheral neuropathies of POEMS syndrome and castleman disease [J]. Hematol Oncol Clin North Am,2018,32(1):153-163.
[13] Mauermann ML,Sorenson EJ,Dispenzier IA,et al. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP [J]. J Neurol Neurosurg Psychiatry,2012,83(5):480-486.
[14] Warsame RY,Kapoor P. POEMS syndrome:an enigma [J]. Curr Hematol Malig Rep,2017,12(2):85-95.
[15] Kourelis TV,Buadi FK,Kumar SK,et al. Long-term outcome of patients with POEMS syndrome:an update of the Mayo Clinic experience [J]. Am J Hematol,2016, 91(6):585-589.
[16] Zagouri F,Kastritis E,Gavriatopoulou M,et al. Lenalidomide in patients with POEMS syndrome:a systematic review and pooled analysis [J]. Leuk Lymphoma,2014,55(9):2018-2023.
[17] Ohwada C,Nakaseko C,Sakai S,et al. Successful combination treatment with bevacizumab,thalidomide and autologous PBSC for severe POEMS syndrome [J]. Bone Marrow Transplant,2009,43(9):739-740.
[18] Misawa S,Sato Y,Katayama K,et al. safety and efficacy of thalidomide in patients with POEMS syndrome:a multicentre,randomised,double-blind,placebo-controlled trial [J]. Lancet Neurol,2016,15(11):1129-1137.
[19] Dispenzieri A. POEMS syndrome:2017 Update on diagnosis,risk stratification,and management [J]. Am J Hematol,2017,92(8):814-829.
[20] Wang C,Huang XF,Cai QQ,et al. Progllostic study for overall survival in patients with newly diagnosed POEMS syndrome [J]. Leukemia,2017,31(1):100-106.
[21] Kourelis TV,Dispenzieri A. alidation of a prognostic score for patients with POEMS syndrome:a mayo clinic cohon [J]. Leukemia,2017,3l(5):1251.